Postdoctoral Associate
Molecular Biology · China · 2022-04-18
Proposed Endeavor
The petitioner proposes to continue her research on the mechanisms of proteins and viruses and the development of state-of-the-art extracellular vesicle engineering, visualization, and purification approaches. Her work focuses on improving therapeutics for a variety of human diseases by developing novel drug platforms and inhibitors against toxins.
Framework Evaluation
3 of 3 criteria metThe research is essential for improving drug performance, reducing costs, and developing inhibitors against ricin, a Category B bioterrorism agent.
The petitioner has 8 years of experience, 6 peer-reviewed publications, 71 citations, and has secured funding from major federal agencies like the NIH and NSF.
On balance, it is beneficial to the U.S. to waive the requirements because her work addresses salient national healthcare and security concerns.
Why This Petition Was Approved
Evidence
Similar Cases
Others
Biotechnology · China
General Manager
Biotechnology · India
Scientist
Biotechnology · China
Others
Pharmaceuticals · Iran
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-18.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist